It is well recognized that different patients respond in different ways to the same medication. The need for patient-specific medicine is clear. GreenMCMeds’ integrated genomic solution, which includes the unique combination of pharmacogenomics testing (PGx) and therapeutic drug monitoring dramatically improves clinical judgment and helps physicians form a more accurate, comprehensive and effective treatment regimen for their patients.
Pharmacogenomics (PGx) is the study of how genes affect a person’s response to drugs. GreenMCMeds' PGx evaluates the patient’s metabolic profile, the potential drug/gene and drug/drug interactions. This test establishes a clear understanding of the patient’s potential drug/gene and drug/drug interaction. Starting with a buccal swab, GreenMCMeds conducts PGx to analyze germ-line variants that may affect how a patient responds to certain drugs. GreenMCMeds identifies patient- specific metabolism for CYP2D6, CYP2C9, CYP2C19, CYP3A4/3A5, CYP1A2, VKORC1, DPYD, TPMT, UGT1A1, Factor II, Factor V, MTHFR, SLCO1B1 and TYMS.
The report will reveal if a patient is an ultra-rapid, extensive, intermediate or poor metabolizer of relevant drugs. Specialties most affected by drug/gene and drug/drug interactions are cardiology, psychiatry, pain and internal medicine.
Potent inhibitors/inducers which may affect the bioavailability of other drugs on profile:
GreenMCMeds provides physicians and patients with immediate actionable, comprehensive reports. These specific diagnostic results, by testing relevant markers, enable physicians to quickly make decisions and identify appropriate therapy. This empowers patients to take a proactive role in their healthcare. The reports are intuitively laid out with every step thoughtfully considered we additionally created an alternative drug assessment for the most commonly used drugs.
Following the initial diagnostics and reports, our staff continuously discusses the clinical implications, giving proactive, predictive recommendations to help physicians improve diagnosis and optimize therapy decisions. GreenMCMeds also offers continual monitoring services and provides information on whether drug dosage adjustment is needed.
Today's prescribers require diagnostic solutions that improve clinical management of patients. GreenMCMeds is a leading diagnostic and medical decision support company dedicated to providing practitioners with medication monitoring. To achieve this, GreenMCMeds uses the latest drug screening technologies that confirms patient compliance with drug regimens, detection of medication duplications (e.g., opiates) and detection of illicit drug use. Used in combination with our pharmacogenomics testing, medication monitoring enables the optimization of drug dosing and the minimization of drug interactions.
GreenMCMeds Medication Monitoring includes:
Highly accurate, clinically relevant reports delivered through a secure online portal for rapid results and quick treatment decisions. Credentialed staff of technologists and PharmDs in a CLIA-certified, high-complexity lab partners.
We understand the risks to both prescriber and patient associated with medications that are not taken as prescribed. By partnering with GreenMCMeds for medication monitoring, prescribers will receive clinical data that ensures improved patient compliance and outcomes, informed support of treatment decisions for proper and effective medication dosing, and lowered rate of prescription drug misuse to increase patient safety and mitigate prescriber liability.
GreenMCMeds’ integrated solution provides a comprehensive view to support physicians and patients on decisions they must make with a proprietary solution utilizing Pharmacogenomics Testing (PGx).
With GreenMCMeds’ integrated genomic diagnostics, you can:
This intuitive pairing dramatically improves clinical judgment and helps physicians form a more accurate, comprehensive and effective treatment regimen with the goal of enhancing a patient’s life and increasing the likelihood of extending his or her life.
Certified molecular biologists, pathologists and technologists conduct tests under innovative protocols and technology much more advanced than industry standards. All tests are conducted with our CLIA-certified, high-complexity lab partners and are under a unique, multilayered quality assurance and control system.
Following the initial diagnostics and reports, our staff is able to review the clinical implications, giving proactive, predictive recommendations to help physicians improve clinical insight and optimize therapy decisions to enhance patients' lives. GreenMCMeds also offers drug-monitoring services and provides information on whether drug dosage adjustment is needed. Our PharmD call center is available to all physicians.
GreenMCMeds grants payers access to genomic data and intelligence to show evidence of lower total costs of care through better treatment decisions. This intentional clinical data collection empowers GreenMCMeds to develop new genomic diagnostics and therapies while identifying broader treatment trends. Also, this data is materially rich for supporting pharmaceutical innovation and clinical trials in personalized medicine.
At GreenMCMeds, we strive to provide our solutions at a cost that can be afforded by those who need it. We accept many health insurance plans. However, if a patient’s insurance does not cover the cost of the lab test, they may qualify for GreenMCMeds’ Patient Financial Assistance Program, which provides payment plans and additional financial support for those who qualify.
DISCLAIMER: GreenMCMeds does not partake in cultivation or dispensing of cannabis in no way, shape, or form, nor are we affiliated with any dispensaries or cultivation sites.